What is included with this book?
List of Illustrations | p. ix |
List of Tables | p. xi |
Acknowledgments | p. xiii |
List of Abbreviations and Acronyms | p. xvii |
Introduction: The Gatekeeper | p. 1 |
Reputation and Regulatory Power | p. 33 |
Organizational Empowerment and Challenge | |
Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath | p. 73 |
The Ambiguous Emergence of American Pharmaceutical Regulation, 1944–1961 | p. 118 |
Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961–1966 | p. 228 |
Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963–1986 | p. 298 |
Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977–1992 | p. 393 |
Pharmaceutical Regulation and Its Audiences | |
Reputation and the Organizational Politics of New Drug Review | p. 465 |
The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite | p. 544 |
The Other Side of the Gate: Reputation, Power, and Post-Market Regulation | p. 585 |
The Détente of Firm and Regulator | p. 635 |
American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies | p. 686 |
Conclusion: A Reputation in Relief | p. 727 |
Primary Sources and Archival Collections | p. 753 |
Index | p. 759 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.